GlassScriptPhysician profile
Elizabeth Bail
NPI 1225503220
$617.84
in general payments reported to CMS, 2019-2025
7 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.93 · 2023: $220 · 2024: $111 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564 · Education: $19.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.39 |
| Education | $19.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $145.13 | 2023-2024 | Menopur |
| Emd Serono, INC. | $141.61 | 2021-2023 | |
| Amgen INC. | $119.56 | 2025 | Evenity |
| Organon LLC | $78.18 | 2023-2024 | Follistim Aq, Ganirelix Acetate |
| Mayne Pharma Commercial LLC | $58.89 | 2025 | |
| Abbvie INC. | $55.88 | 2025 | |
| Exeltis, USA INC. | $18.59 | 2025 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Bail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.